ABPI

News and analysis related to the Association of the British Pharmaceutical Industry (ABPI).

News and analysis related to the Association of the British Pharmaceutical Industry (ABPI).

UK parliament backs EU trade deal, as industry sifts through detail

The post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some

Share

X

UK parliament backs EU trade deal, as industry sifts through detail

https://pharmaphorum.com/news/uk-parliament-backs-eu-trade-deal-as-industry-sifts-through-detail/

2020 in review: COVID-19 and patient centric clinical trials

The trials and tribulations of 2020 have brought the vital role of research, pharma, and biotech into sharp

Share

X

2020 in review: COVID-19 and patient centric clinical trials

https://pharmaphorum.com/views-analysis-patients/2020-in-review-covid-19-and-patient-centric-clinical-trials/

Health inequalities: A societal challenge that needs a cross-sector solution

COVID-19 has laid the UK’s health inequalities bare and created an imperative for the NHS to develop a

Share

X

Health inequalities: A societal challenge that needs a cross-sector solution

https://pharmaphorum.com/views-and-analysis/health-inequalities-a-societal-challenge-that-needs-a-cross-sector-solution/

ABPI chief exec on the UK industry’s learnings from COVID-19

The ABPI’s chief executive Dr Richard Torbett shares his views on how the industry has adapted to COVID-19

Share

X

ABPI chief exec on the UK industry’s learnings from COVID-19

https://pharmaphorum.com/views-analysis-market-access/abpi-chief-exec-on-the-uk-industrys-learnings-from-covid/

Brexit could hinder access to coronavirus vaccines, says pharma group

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus

Share

X

Brexit could hinder access to coronavirus vaccines, says pharma group

https://pharmaphorum.com/news/brexit-could-hinder-access-to-coronavirus-vaccines-says-pharma-group/

Government needs strategy to kick-start R&D after COVID, says pharma body

The UK has been leading research into the COVID-19 outbreak, according to the country’s pharma trade body, but

Share

X

Government needs strategy to kick-start R&D after COVID, says pharma body

https://pharmaphorum.com/news/uk-pharma-calls-for-non-covid-research-to-restart/

Behind the scenes of the new ABPI Code of Practice

For over 60 years the ABPI Code of Practice has been key to the UK industry’s self-regulation, and

Share

X

Behind the scenes of the new ABPI Code of Practice

https://pharmaphorum.com/views-and-analysis/behind-the-scenes-of-the-new-abpi-code-of-practice/

Tackling multimorbidity through collaboration

As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems. A new action group from the

Share

X

Tackling multimorbidity through collaboration

https://pharmaphorum.com/views-analysis-patients/tackling-multimorbidity-through-collaboration/

Fearing Brexit chaos, UK asks pharma to build six-week drug stockpile

The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping

Share

X

Fearing Brexit chaos, UK asks pharma to build six-week drug stockpile

https://pharmaphorum.com/news/uk-asks-pharma-companies-to-build-six-week-stockpile-as-brexit-approaches/